Safety and Efficacy of IV CXA-101 and IV Ceftazidime in Patients With Complicated Urinary Tract Infections

This study has been completed.
Sponsor:
Information provided by:
Calixa Therapeutics, Inc.
ClinicalTrials.gov Identifier:
NCT00921024
First received: June 12, 2009
Last updated: August 5, 2010
Last verified: August 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2010
  Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)